z-logo
Premium
The identification of in vitro metabolites of CKD‐732 by liquid chromatography/tandem mass spectrometry
Author(s) -
Myung SeungWoon,
Kim HyeYoung,
Min HyeKi,
Kim DongHyun,
Kim Myungsoo,
Cho HyunWoo,
Lee Ho Sup,
Kim JoonKyum,
Hong Chung II
Publication year - 2002
Publication title -
rapid communications in mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.528
H-Index - 136
eISSN - 1097-0231
pISSN - 0951-4198
DOI - 10.1002/rcm.830
Subject(s) - chemistry , chromatography , metabolite , high performance liquid chromatography , tandem mass spectrometry , mass spectrometry , electrospray ionization , liquid chromatography–mass spectrometry , electrospray , biochemistry
The structural elucidation of fourteen metabolites of CKD‐732, formed in vitro with rat liver microsomes, was performed using high‐performance liquid chromatography/electrospray ionization‐tandem mass spectrometry (HPLC/ESI‐MS/MS). To identify proposed structures of the metabolites, the product ion mass spectra of the protonated molecules ([M + H] + ), the retention times on reversed‐phase HPLC, and UV‐Vis spectra were utilized. Characteristic product ions for the identification of CKD‐732 metabolites were observed at m/z 231, 236, and 252. The fragment ions at m/z 236 and 252 indicated the unchanged form and the N‐oxide of the dimethylaminoethoxycinnamoyl group, respectively. The ion at m/z 231 indicated the presence of the hydroxylated form of the fumagillol group. The N‐oxide of CKD‐732, which was detected at m/z 515 and eluted later than CKD‐732 in the reversed‐phase HPLC system, was measured as a major metabolite. Three cis‐trans isomers were also found. Copyright © 2002 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom